Clinical Trial Update: Cost Effectiveness Of Linezolid In Central America

View source ↗

Summary

A Pfizer-sponsored clinical trial evaluating the cost-effectiveness of linezolid for ventilator-associated pneumonia in Central America has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: Pfizer | Conditions: Ventilator Acquired Pneumonia | Status: WITHDRAWN